Ind Swift Lab get USFDA nod for 5 products; stock gains

Shares of Ind Swift Laboratories surged higher as the company got USFDA approval for 5 active pharmaceutical ingredients at its Derabassi plant in Punjab. The company is expecting approval for 12 products from USFDA in current year.

The stock was at Rs 101.15, up 3.74 per cent on the BSE. It touched a high of Rs 102.90 and low of Rs 98 in trade so far.